We also identified an additional thirteen cases with evidence of annexin A11 pathology including eight AD cases with LATE-NC, two FTLD–TDP Type A cases, one FTLD–TDP Type B case, and two ALS cases (Table 2). Here, ANXA11 is linked to Alzheimer disease.